Evidence map›Paper›PMID 25556921›Full record

ArticleNeuro-oncology2015

Comparison of immunohistochemistry and DNA sequencing for the detection of IDH1 mutations in gliomas.

Yingjie Zou, Harrison Xiao Bai, Zhili Wang, Li Yang

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yingjie ZouDepartment of Neurology, The Second Xiangya Hospital, Central South University, Hunan, China (Y.Z., Z.W., L.Y.); Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (H.X.B.).
Harrison Xiao BaiDepartment of Neurology, The Second Xiangya Hospital, Central South University, Hunan, China (Y.Z., Z.W., L.Y.); Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (H.X.B.).
Zhili WangDepartment of Neurology, The Second Xiangya Hospital, Central South University, Hunan, China (Y.Z., Z.W., L.Y.); Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (H.X.B.).
Li YangDepartment of Neurology, The Second Xiangya Hospital, Central South University, Hunan, China (Y.Z., Z.W., L.Y.); Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (H.X.B.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Models, StatisticalBiomarkers, TumorBrain NeoplasmsFemaleGliomaHumansIsocitrate DehydrogenaseMaleMutationBiomarkers, TumorIsocitrate Dehydrogenase

Identifiers

PMID25556921
PMCPMC4483104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.